Luo Li, Liu Xi-Jiao, Chen Dong-Ling, Deng Xiao-Ya, Pan Yong-Hong, Li Sheng
Department of Respiratory Medicine, Shapingba Hospital affiliated to Chongqing University (Shapingba District People's Hospital of Chongqing), Chongqing, Shapingba District, 400040, People's Republic of China.
Bishan Hospital of Chongqing Medical University (Bishan Hospital of Chongqing), Chongqing, Bishan District, 402760, People's Republic of China.
Infect Drug Resist. 2024 Oct 23;17:4617-4624. doi: 10.2147/IDR.S477984. eCollection 2024.
This study aims to evaluate the clinical efficacy of integrated traditional Chinese and Western medicine rehabilitation treatment during the recovery period of COVID-19, providing a scientific basis for developing more effective rehabilitation protocols.
The study included 120 COVID-19 (novel coronavirus) recovery patients treated at our hospital from November 2021 to April 2022. After registration, patients were randomly divided into two groups, namely the study group and the control group. The control group received conventional rehabilitation treatment, while the study group underwent integrated traditional Chinese and Western medicine rehabilitation treatment, with 60 cases in each group. The clinical observation indicators in this study include the results of the 6-minute walk test (6MWT), respiratory and circulatory parameters, pulmonary function, changes in respiratory muscle strength, and quality of life in both groups of patients.
The 6MWT distance increased significantly in both groups, with the study group showing a larger improvement (P < 0.05). SpO2 and PaO2 values improved significantly in both groups, with greater increases in the study group (P < 0.05). Lung function parameters (FEV1 and FEV1/FVC) improved significantly in the study group compared to the control group (P < 0.05). Diaphragmatic thickness and mobility were also significantly higher in the study group (P < 0.05). The SF-36 quality of life scores were significantly better in the study group (P < 0.05).
Integrated traditional Chinese and Western medicine rehabilitation treatment has achieved significant efficacy during the recovery period of COVID-19. The complementary use of traditional Chinese medicine's differential diagnosis and treatment and modern medical approaches from Western medicine provides patients with comprehensive and personalized rehabilitation services, offering new ideas and methods to improve the quality of patient recovery.
本研究旨在评估中西医结合康复治疗在新型冠状病毒肺炎（COVID-19）恢复期的临床疗效，为制定更有效的康复方案提供科学依据。
本研究纳入了2021年11月至2022年4月在我院接受治疗的120例COVID-19康复患者。登记后，患者被随机分为两组，即研究组和对照组。对照组接受常规康复治疗，而研究组接受中西医结合康复治疗，每组60例。本研究中的临床观察指标包括两组患者的6分钟步行试验（6MWT）结果、呼吸和循环参数、肺功能、呼吸肌力量变化以及生活质量。
两组患者的6MWT距离均显著增加，研究组改善幅度更大（P<0.05）。两组患者的SpO2和PaO2值均显著改善，研究组升高幅度更大（P<0.05）。与对照组相比，研究组的肺功能参数（FEV1和FEV1/FVC）显著改善（P<0.05）。研究组的膈肌厚度和活动度也显著更高（P<0.05）。研究组的SF-36生活质量评分显著更好（P<0.05）。
中西医结合康复治疗在COVID-19恢复期取得了显著疗效。中医辨证论治与西医现代医学方法的互补应用为患者提供了全面、个性化的康复服务，为提高患者康复质量提供了新的思路和方法。
